Author

Katrina Salvador

Observed name: K. Salvador

Observed institution: Synthetic Genomics (United States)

OpenAlex ID: A5039736734

Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma

2024 · Fanching Lin, Renee Clift, et al. · Journal of Nuclear Medicine · 57

Self-Replicating RNAs Drive Protective Anti-tumor T Cell Responses to Neoantigen Vaccine Targets in a Combinatorial Approach

2020 · Christian J. Maine, Guilhem Richard, et al. · Molecular Therapy · 28

Novel GPC3-targeting radiopharmaceutical therapy for hepatocellular carcinoma.

2024 · Fanching Lin, Renee Clift, et al. · Journal of Clinical Oncology · 4

Abstract 6020: GPC3-targeted radiopharmaceutical therapy for neuroendocrine prostate cancer

2024 · Renee Clift, Fanching Lin, et al. · Cancer Research · 2

Novel peptide binder for EphA2-targeted radiopharmaceutical therapy for multiple solid tumors.

2023 · Renee Clift, Samantha Richardson, et al. · Journal of Clinical Oncology · 1

Novel peptide binder to Glypican-3 for targeted radiopharmaceutical therapy of hepatocellular carcinoma.

2023 · Gary Li, Fanching Lin, et al. · Journal of Clinical Oncology · 1

Abstract 571: Novel somatostatin receptor type 2 targeted radiopharmaceuticals with improved renal clearance and enhanced tumor retention relative to DOTATATE

2025 · Nicole Bakas, Alain Noncovich, et al. · Cancer Research

676P Preclinical characterization of novel peptide binders for EphA2-targeted radiopharmaceutical therapy

2023 · R. Clift, S. Richardson, et al. · Annals of Oncology

Works count: 8

Citation count: 93

H-index: 3

I10-index: 2